Jean-François RENUCCI (@jf_renucci) 's Twitter Profile
Jean-François RENUCCI

@jf_renucci

Service de Médecine Vasculaire et Hypertension Artérielle Marseille fr.ap-hm.fr/service/medeci…

ID: 1273316556244688896

linkhttp://cprv.fr calendar_today17-06-2020 18:08:36

879 Tweet

167 Takipçi

190 Takip Edilen

Dr Alo, DO, FACC (@mohammedalo) 's Twitter Profile Photo

Inclisiran For Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia New 1-year double-blind, placebo-controlled Phase 3 data from ORION-13 show: 1️⃣ Placebo-adjusted LDL-C dropped by 33.3% and PCSK9 by 60.2% at Day 330. 2️⃣ ApoB and non-HDL-C reduced

Inclisiran For Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia

New 1-year double-blind, placebo-controlled Phase 3 data from ORION-13 show:

1️⃣ Placebo-adjusted LDL-C dropped by 33.3% and PCSK9 by 60.2% at Day 330.

2️⃣ ApoB and non-HDL-C reduced
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

Most viewed this week from JAMA Cardiology: Chronic cannabis smoking and THC ingestion were associated with endothelial dysfunction similar to that observed in tobacco smokers. ja.ma/4kjPfWr

Most viewed this week from <a href="/JAMACardio/">JAMA Cardiology</a>: 

Chronic cannabis smoking and THC ingestion were associated with endothelial dysfunction similar to that observed in tobacco smokers.  

ja.ma/4kjPfWr
SFMV (@lasfmv) 's Twitter Profile Photo

Webinar SFMV : Jeudi 5 Juin à. 20.00 " Thrombopénie Immuno-allergique à l'Héparine (TIH) " avec pas moins de 3 experts pour répondrent à vos questions. SAVE THE DATE : webinars.sfmv.fr

Webinar SFMV : Jeudi 5 Juin  à. 20.00 " Thrombopénie Immuno-allergique à l'Héparine (TIH) " avec pas moins de 3 experts pour répondrent à vos questions. SAVE THE DATE : webinars.sfmv.fr
Ahmed Ata (@ahmedata7777) 's Twitter Profile Photo

Anticoagulation in PE overview: Anticoagulation is the mainstay of treatment for pulmonary embolism (PE), aiming to prevent further thrombus formation, reduce the risk of clot propagation, and allow the body to naturally lyse the existing clot. 1. Initial Anticoagulation (First

Anticoagulation in PE overview:

Anticoagulation is the mainstay of treatment for pulmonary embolism (PE), aiming to prevent further thrombus formation, reduce the risk of clot propagation, and allow the body to naturally lyse the existing clot.

1. Initial Anticoagulation (First
The Lancet Diabetes & Endocrinology (@thelancetendo) 's Twitter Profile Photo

Catecholamine-induced hypertensive crises: current insights and management thelancet.com/journals/landi… #phaeochromocytomas #paragangliomas #PPGLs

Catecholamine-induced hypertensive crises: current insights and management thelancet.com/journals/landi…
#phaeochromocytomas #paragangliomas #PPGLs
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴The Brussels International Declaration on Lipoprotein(a) Testing and Management⤵️ May 04, 2025 #OpenAccess 🔹atherosclerosis-journal.com/article/S0021-… #ECG #preparticipationscreening #SCD #Athlete #Sportscardiology #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd

🔴The Brussels International Declaration on Lipoprotein(a) Testing and Management⤵️  
May 04, 2025  #OpenAccess

🔹atherosclerosis-journal.com/article/S0021-…
#ECG #preparticipationscreening #SCD #Athlete #Sportscardiology
 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd
Dr Alo, DO, FACC (@mohammedalo) 's Twitter Profile Photo

ApoB, LDL-C and Non-HDL-C as Markers of CVD Risk New systematic review from allan sniderman analyzed discordance studies to identify the most accurate marker of ASCVD risk. 1️⃣ ApoB outperformed LDL-C in 9/9 studies and non-HDL-C in 7/9 studies. 2️⃣ LDL-P was superior to LDL-C

ApoB, LDL-C and Non-HDL-C as Markers of CVD Risk

New systematic review from allan sniderman analyzed discordance studies to identify the most accurate marker of ASCVD risk.

1️⃣ ApoB outperformed LDL-C in 9/9 studies and non-HDL-C in 7/9 studies.

2️⃣ LDL-P was superior to LDL-C
EJPC Editor-in-Chief (@ejpceic) 's Twitter Profile Photo

In your practice, do you use the SCORE2-OP to predict 10-year cardiovascular risk in the elderly? 🤔 In this study, SCORE2-OP showed notable discrimination and excellent calibration to predict 10-year CV risk, with better performance in females. 📗👉academic.oup.com/eurjpc/article…

In your practice, do you use the SCORE2-OP to predict 10-year cardiovascular risk in the elderly? 🤔 
In this study, SCORE2-OP showed notable discrimination and excellent calibration to predict 10-year CV risk, with better performance in females. 
📗👉academic.oup.com/eurjpc/article…
SFMV (@lasfmv) 's Twitter Profile Photo

Aujourd'hui 4ème édition de la Journée Niçoise du Lymphoedème à suivre sur le web. Patients, professionnels de santé font le point sur l'actu du lymphoedème jnl2025.fr

Aujourd'hui 4ème édition de la Journée Niçoise du Lymphoedème à suivre sur le web. Patients, professionnels de santé font le point sur l'actu du lymphoedème jnl2025.fr